11.05.2017 12:00:00
|
NDS receives FDA clearance for ZeroWire Mobile battery-powered display stand
SAN JOSE, Calif., May 11, 2017 /PRNewswire/ -- NDS today announced it has received FDA 510(k) clearance for its new ZeroWire®Mobile battery-powered display stand solution. Designed to enable the untethered clinical mobility of endoscopy displays, ZeroWire Mobile eliminates the display power cord, which combined with ZeroWire wireless video, enables a streamlined, easy-to-use mobile imaging solution that can be moved efficiently within the procedure room, and quickly relocated from room to room throughout the facility.
ZeroWire Mobile is designed as an accessory and engineered to support two cleanable battery power modules. With both power modules fully charged, the display stand can power an NDS 32" monitor for up to five hours of continuous operation. Colored LED light bars display battery strength and indicate when a power module requires re-charging. A simple "hot-swap" process allows the user to swap power modules immediately from a wall-mounted charging system.
"NDS is focused solely on the medical industry, and takes great pride in delivering innovative products that can help increase efficiency for the clinical staff," said Darko Spoljaric, Vice President of Global Marketing at NDS. "ZeroWire Mobile is designed specifically for the endoscopic environment, with a view to providing a medical-grade, easy-to-use, highly mobile imaging solution."
A core component of a patent-pending solution ideal for endoscopy applications where a secondary monitor is required with the added benefit of easy maneuverability, ZeroWire Mobile can help reduce clutter and minimize tripping hazards for the staff in the OR. By eliminating the need to clean and maintain cables, room turnaround may be streamlined.
Learn more about the new ZeroWire Mobile display stand by visiting www.ndssi.com/mobile.
About NDS
Headquartered in Silicon Valley, CA, NDS is a global leader in designing and manufacturing endoscopy visualization, video processing, and wireless imaging systems. NDS technology solutions have led the way in re-defining modern operating rooms and endoscopy suites.
At the forefront of innovation in medical imaging technology, NDS delivers HD visualization products that enable the clinical imaging solutions of the future, and drive constant improvements in collaborative medicine. NDS, a Novanta Company, has US-based R&D and manufacturing facilities, and a global presence in more than 35 countries.
About Novanta
Novanta is a leading global supplier of core technology solutions that give advanced industrial and healthcare OEMs a competitive advantage. We combine deep expertise at the intersection of photonics and motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. We deliver highly engineered laser, vision and precision motion solutions to customers around the world. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta's common shares are quoted on NASDAQ under the ticker symbol "NOVT."
Contact:
Andy Larg
alarg@ndssi.com
(408) 754-4255
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nds-receives-fda-clearance-for-zerowire-mobile-battery-powered-display-stand-300455721.html
SOURCE NDS
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu GSI Group Incmehr Nachrichten
04.11.24 |
Ausblick: GSI Group mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
21.10.24 |
Erste Schätzungen: GSI Group präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
05.08.24 |
Ausblick: GSI Group präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
22.07.24 |
Erste Schätzungen: GSI Group stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |